Emergent BioSolutions Q4 Adj. EPS $3.67 Beats $3.19 Estimate, Sales $583.00M Beat $563.60M Estimate

Benzinga2021-02-19

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $3.67 per share which beat the analyst consensus estimate of $3.19 by 15.05 percent. This is a 133.76 percent increase over earnings of $1.57 per share from the same period last year. The company reported quarterly sales of $583.00 million which beat the analyst consensus estimate of $563.60 million by 3.44 percent. This is a 61.76 percent increase over sales of $360.40 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
1